Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid Cancer
Authors:
- 29 October 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (4) , 1028-1034
Abstract
The relationship between extent of cervical lymphadenectomy along with the number of involved lymph nodes (LNs) removed and overall survival has not been well documented in patients with medullary thyroid carcinoma (MTC). This study investigates whether the overall number of LNs removed and the number of metastatic LNs are independent prognostic factors for overall survival. Data from patients with MTC in the Surveillance, Epidemiology, and End Results (SEER) registry database were examined. After categorizing the study population based on the number of overall LNs examined and the number of metastatic LNs, survival estimates were compared. The total number of examined LNs and their histopathological status were analyzed for their prognostic value in estimating overall survival. 593 patients were included in this study. Those with all negative LNs had the best overall survival; those with LNs examined and at least one positive LN had worst overall survival (p < 0.0001). The total number of examined LNs for both groups with negative and positive LNs was not associated with improved survival outcome (p = 0.41). In node-positive patients, each additional positive LN was significantly associated with an increase in overall mortality [hazard ratio (HR) = 1.05, 95% confidence interval (CI) = 1.02–1.08]. Cervical LN metastases conferred an independent risk for worse survival rate in MTC. Cervical lymphadenectomy is important for staging and regional disease control, however the extent of lymph node dissection, the overall number of lymph nodes removed along with removal of an increased number of involved lymph nodes do not confer a survival advantage. Future prospective studies are needed.Keywords
This publication has 14 references indexed in Scilit:
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid AssociationThyroid®, 2009
- Long‐term Outcome of Reoperations for Medullary Thyroid CarcinomaWorld Journal of Surgery, 2008
- Medullary Thyroid Cancer: Monitoring and TherapyEndocrinology and Metabolism Clinics of North America, 2007
- Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patientsEuropean Journal of Surgical Oncology, 2007
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Extent of Disease and Practice Patterns for Medullary Thyroid CancerJournal of the American College of Surgeons, 2005
- Guidelines for the management of thyroid cancerClinical Endocrinology, 2003
- The management of thyroid cancer in adults: a review of new guidelinesClinical Medicine, 2002
- Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinomaClinical Endocrinology, 2001
- Medullary Carcinoma of the ThyroidMedicine, 1984